Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclesonide onset of action in seasonal allergic rhinitis
NCT00659503Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2005
- Primary completion
- Apr 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ciclesonide in seasonal allergic rhinitis (SAR), sponsored by AstraZeneca. Started Feb 2005; status: completed.
02
Drugs
ciclesonide
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00659503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00659503.